Home > News > Juul publishes 9 vape related research results

Juul publishes 9 vape related research results

Views: 306 Update date: May 27,2020

On March 14, local time, Juul announced the results of its nine scientific and research projects at the 2020 annual meeting of the Nicotine and Tobacco Research Society (SRNT) in New Orleans. The company's research covers a wide range and contributes to the growing scientific evidence of vape products.

The following is a complete list of JUUL laboratory research shared digitally on SRNT 2020:

1. Pharmacokinetic and pharmacodynamic evaluation of adult smokers using vape combustible cigarettes and nicotine chewing gum;

2. The use of flavored vape among underage smokers and subsequent smoking;

3. The relationship between the subjective effect of the initial vape use and the subsequent vape use and smoking among smokers and former smokers;

4. Longitudinal study on factors related to continuous smoking and isolated smoking behavior of adult smokers (NES) using vape;

5. Factors related to the regular use of vape in adult smokers who quit smoking with combustible cigarettes;

6. Cigarette smoking and relapse behavior of adult smokers who use vape to stop smoking: a 12-month longitudinal study;

7. Preliminary findings of a pilot program for a new system designed to improve retailers' compliance with tobacco product purchases;

8. Use an electronic low-pressure impactor to analyze the particle size distribution of the vape aerosol in the liquefaction phase in real time;

9. The influence of smoking on the usage and conversion behavior of flavored vape.

Juul stated that Juul has been conducting and supporting non-clinical, clinical and behavioral research to study the impact of JUUL products on public health and is committed to working with regulatory agencies, public health officials and other stakeholders to preserve historic opportunities , So that adult smokers can get rid of cigarettes from combustible people, and at the same time combat the use of minors. The company will continue its efforts to transparently share the results of its scientific and research programs with the public health community in an effort to support this category of scientific evidence and future regulatory filings.